Medicare Enrolled
Dr. Anil Bhogaraju, MD
Hematology & Oncology · Lewisville, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bhogaraju from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bhogaraju? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bhogaraju
Dr. Anil Bhogaraju is a hematology & oncology in Lewisville, TX, with 19 years in practice. Based on federal Medicare data, Dr. Bhogaraju performed 57,921 Medicare services across 2,893 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bhogaraju received a total of $4,687 from 51 pharmaceutical and/or device companies across 213 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bhogaraju is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 16% volume in TX$ $4,687 industry payments
Medicare Practice Summary
Medicare Utilization ↗57,921
Medicare services
Top 16% in TX for hematology & oncology
2,893
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,048 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 11,600 | $43 | $137 |
| Iron sucrose injection (Venofer) | 8,500 | $0 | $2 |
| Darbepoetin injection (Aranesp) for anemia | 7,750 | $2 | $20 |
| Anti-nausea injection (fosaprepitant) | 6,300 | $0 | $5 |
| Contrast dye for imaging (iodine-based) | 6,205 | $0 | $3 |
| Paclitaxel chemotherapy injection | 3,946 | $0 | $8 |
| Denosumab injection (Prolia/Xgeva) | 3,180 | $18 | $66 |
| Injection, granisetron hydrochloride, 100 mcg | 1,700 | $0 | $24 |
| Dexamethasone injection (steroid) | 1,534 | $0 | $1 |
| Blood draw (venipuncture) | 952 | $8 | $20 |
| Complete blood count (CBC) with differential | 834 | $8 | $36 |
| Comprehensive metabolic blood panel | 722 | $10 | $64 |
| Anti-nausea injection (Aloxi/palonosetron) | 600 | $1 | $114 |
| Office visit, established patient (30-39 min) | 446 | $93 | $368 |
| Office visit, established patient (20-29 min) | 318 | $62 | $250 |
| Administration of chemotherapy into vein, 1 hour or less | 285 | $98 | $707 |
| Injection of additional new drug or substance into vein | 239 | $12 | $108 |
| Injection, zoledronic acid, 1 mg | 223 | $7 | $431 |
| Injection, carboplatin, 50 mg | 196 | $2 | $300 |
| Ferritin level test (iron stores) | 161 | $13 | $60 |
| Iron level test | 161 | $6 | $27 |
| Iron binding capacity test | 161 | $9 | $35 |
| Drug injection, under skin or into muscle | 135 | $10 | $96 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 124 | $48 | $313 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 109 | $22 | $157 |
| Magnesium level test | 101 | $7 | $29 |
| Infusion, normal saline solution , 1000 cc | 101 | $2 | $19 |
| Infusion into a vein for hydration, each additional hour | 83 | $9 | $75 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 81 | $55 | $211 |
| Thyroid stimulating hormone (TSH) test | 74 | $16 | $80 |
| Administration of additional new drug or substance into vein, 1 hour or less | 72 | $49 | $344 |
| New patient office visit (45-59 min) | 62 | $119 | $565 |
| Injection, diphenhydramine hcl, up to 50 mg | 59 | $1 | $7 |
| Administration of chemotherapy into vein, each additional hour | 56 | $21 | $161 |
| Ct scan of chest with contrast | 55 | $54 | $821 |
| Vitamin B-12 level test | 53 | $15 | $76 |
| Microscopic examination for white blood cells with manual cell count | 52 | $4 | $22 |
| Complete blood count (CBC), automated | 52 | $6 | $34 |
| Prothrombin time test (blood clotting) | 50 | $4 | $30 |
| Irrigation of implanted venous access drug delivery device | 50 | $19 | $114 |
| CT scan of abdomen and pelvis with contrast | 49 | $175 | $1,067 |
| Unclassified drugs | 47 | $1 | $8 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 39 | $90 | $657 |
| Injection of drug or substance into vein | 36 | $27 | $247 |
| Measurement of immunoglobulin light chains | 34 | $17 | $60 |
| Infusion into a vein for hydration, 31-60 minutes | 34 | $25 | $256 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 32 | $1,114 | $4,802 |
| Lactate dehydrogenase (enzyme) level | 31 | $6 | $31 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 29 | $16 | $100 |
| Red blood count automated, with additional calculations | 27 | $5 | $26 |
| Reticulated (young) platelet measurement | 27 | $35 | $143 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 27 | $26 | $145 |
| Hospital follow-up visit, moderate complexity | 26 | $61 | $247 |
| Stool analysis for blood to screen for colon tumors | 23 | $4 | $24 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 23 | $178 | $700 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 22 | $1 | $17 |
| CT scan of chest, without contrast | 20 | $48 | $686 |
| Manual urinalysis test with examination using microscope, non-automated | 13 | $4 | $26 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.8% high complexity
91.3% medium
7.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,687
Total received (2018-2024)
Avg $670/year across 7 years
Top 44% in TX for hematology & oncology
51
Companies
213
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,661 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$26 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,837
2023$1,662
2022$740
2021$32
2020$21
2019$195
2018$201
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$288
Merck Sharp & Dohme LLC
$275
PFIZER INC.
$232
ABBVIE INC.
$225
Celgene Corporation
$200
Amgen Inc.
$196
Seagen Inc.
$185
E.R. Squibb & Sons, L.L.C.
$183
Genentech USA, Inc.
$181
Gilead Sciences, Inc.
$180
AstraZeneca Pharmaceuticals LP
$161
PharmaEssentia USA Corporation
$138
Boehringer Ingelheim Pharmaceuticals, Inc.
$132
Adaptive Biotechnologies Corporation
$123
GENZYME CORPORATION
$115
Janssen Biotech, Inc.
$105
Incyte Corporation
$105
ARRAY BIOPHARMA INC
$103
Kite Pharma, Inc.
$102
Eisai Inc.
$98
Blueprint Medicines Corporation
$97
EMD Serono, Inc.
$88
Astellas Pharma US Inc
$84
Daiichi Sankyo Inc.
$83
GlaxoSmithKline, LLC.
$68
Stemline Therapeutics Inc.
$68
SOBI, INC
$63
Regeneron Healthcare Solutions, Inc.
$59
JAZZ PHARMACEUTICALS INC.
$57
Karyopharm Therapeutics Inc.
$54
Mirati Therapeutics, Inc.
$54
Bayer Healthcare Pharmaceuticals Inc.
$51
Apellis Pharmaceuticals, Inc.
$48
ADC Therapeutics America, Inc.
$46
MorphoSys, US Inc.
$44
TAIHO ONCOLOGY, INC.
$44
Merck Sharp & Dohme Corporation
$43
Lilly USA, LLC
$33
Takeda Pharmaceuticals U.S.A., Inc.
$31
Ipsen Biopharmaceuticals, Inc
$28
Exelixis Inc.
$26
TESARO, Inc.
$25
G1 Therapeutics, Inc.
$23
Coherus Biosciences Inc.
$23
EISAI INC.
$22
Dendreon Pharmaceuticals LLC
$21
ImmunoGen, Inc.
$21
Clovis Oncology, Inc.
$19
Taiho Oncology, Inc.
$16
Pharmacyclics LLC, An AbbVie Company
$12
Acrotech Biopharma LLC
$12
Top 3 companies account for 17.0% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · AYVAKIT · Alecensa · Aranesp · BAVENCIO · BELEODAQ · BESREMI · BOSULIF · BRAFTOVI · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · COSELA · DARZALEX · DOPTELET · ELAHERE · ELIQUIS · ELREXFIO · ELZONRIS · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · Elahere · Empaveli · Enhertu · Fabhalta · GILOTRIF · IBRANCE · IMBRUVICA · INLYTA · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · NINLARO · Neulasta · Nplate · ONUREG · OPDIVO · OPDUALAG · Orserdu · PADCEV · PLUVICTO · PROMACTA · PROVENGE · Padcev · Polivy · Pomalyst · REBLOZYL · Rubraca · SARCLISA · SCEMBLIX · Stivarga · TECVAYLI · TEPMETKO · TUKYSA · Tazverik · Trodelvy · Udenyca · VENCLEXTA · VERZENIO · VONJO · Venclexta · XALKORI · XPOVIO · XTANDI · Xtandi · Yescarta · ZEJULA · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $8 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
130
Per 100K population
13.7
County median income
$108,185
Nearest hospital
MEDICAL CITY LEWISVILLE
2.8 mi
2.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Bhogaraju is a mixed practice specialist, with above-average Medicare volume (top 16% in TX), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Bhogaraju experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Bhogaraju performed 11,600 pembrolizumab injection (keytruda) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bhogaraju receive payments from pharmaceutical companies?
Yes. Dr. Bhogaraju received a total of $4,687 from 51 companies across 213 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bhogaraju's costs compare to other hematology & oncologys in Lewisville?
Dr. Bhogaraju's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bhogaraju) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Lewisville
Browse hematology & oncologys in Lewisville ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in TX
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in TX
Which TX hematology & oncologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology